Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264,351,875
Number of holders
63
Total 13F shares, excl. options
24,863,205
Shares change
-5,860,379
Total reported value, excl. options
$103,919,915
Value change
-$23,835,362
Put/Call ratio
13.47%
Number of buys
31
Number of sells
-34
Price
$4.18

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2022

82 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q4 2022.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24,863,205 shares of 264,351,875 outstanding shares and own 9.41% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7,182,850 shares), Cederberg Capital Ltd (2,215,385 shares), VANGUARD GROUP INC (2,087,032 shares), BlackRock Inc. (1,990,454 shares), MORGAN STANLEY (1,591,271 shares), Artal Group S.A. (850,000 shares), BANK OF AMERICA CORP /DE/ (841,386 shares), JPMORGAN CHASE & CO (777,545 shares), Temasek Holdings (Private) Ltd (566,650 shares), and UBS Group AG (543,472 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.